Abstract
This review article encompasses the historical perspective of androgen deprivation therapy by first reviewing the early research conducted by Huggins and Hodge, followed by a cellular biological discussion of androgen receptors in prostate cancer (PCa) physiology, leading to a subsequent discussion of the risk and potential therapeutic role of testosterone therapy in localized, oligometastatic, and metastatic PCa.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
